Perospirone normalized P300 and cognitive function in a case of early psychosis

Journal of Clinical Psychopharmacology

Volumn 33, Issue 2, 2013, Pages 263-266

  Higuchi, Yuko ^a   Sumiyoshi, Tomiki ^a   Ito, Toru ^a   Suzuki, Michio ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PEROSPIRONE;

ACADEMIC ACHIEVEMENT; ADOLESCENT; AUDITORY HALLUCINATION; CASE REPORT; COGNITION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DSM-IV-TR; EVENT RELATED POTENTIAL; HUMAN; LETTER; MALE; PERSECUTORY DELUSION; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; COGNITION DISORDERS; EVENT-RELATED POTENTIALS, P300; HUMANS; ISOINDOLES; MALE; SCHIZOPHRENIA; THIAZOLES; TREATMENT OUTCOME;

EID: 84874930492     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318287c527     Document Type: Letter

References (20)

1. Kawasaki Y, Sumiyoshi T, Higuchi Y, et al. Voxel-based analysis of P300 electrophysiological topography associated with positive and negative symptoms of schizophrenia. Schizophr Res. 2007;94: 164-171. (Pubitemid 47031594)
2. Higuchi Y, Sumiyoshi T, Kawasaki Y, et al. Electrophysiological basis for the ability of olanzapine to improve verbal memory and functional outcome in patients with schizophrenia: a LORETA analysis of P300. Schizophr Res. 2008;101:320-330.
3. Ozgurdal S, Gudlowski Y, Witthaus H, et al. Reduction of auditory event-related P300 amplitude in subjects with at-risk mental state for schizophrenia. Schizophr Res. 2008;105:272-278.
4. Frommann I, Brinkmeyer J, Ruhrmann S, et al. Auditory P300 in individuals clinically at risk for psychosis. Int J Psychophysiol. 2008;70:192-205.
5. Gonul AS, Suer C, Coburn K, et al. Effects of olanzapine on auditory P300 in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:173-177. (Pubitemid 36126660)
6. Sumiyoshi T, Higuchi Y, Itoh T, et al. Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a three-dimensional analysis with sloreta. Psychiatry Res. 2009;172:180-183.
7. Jackson H, McGorry P. The Recognition and Management of Early Psychosis. Cambridge, UK: Cambridge University Press; 2009.
8. Sumiyoshi T, Kawasaki Y, Suzuki M, et al. Neurocognitive assessment and pharmacotherapy towards prevention of schizophrenia: what can we learn from first episode psychosis. Clin Psychopharmacol Neurosci. 2008;6:57-64.
9. Mizuno M, Suzuki M, Matsumoto K, et al. Clinical practice and research activities for early psychiatric intervention at Japanese leading centers. Early Interv Psychiatry. 2009;3:5-9.
10. Yung AR, Yuen HP, McGorry PD, et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry. 2005;39:964-971. (Pubitemid 43904432)
11. Andreasen NC. Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: University of Iowa; 1983.
12. Andreasen NC. Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa; 1983.
13. Kaneda Y, Sumiyoshi T, Keefe R, et al. Brief assessment of cognition in schizophrenia: validation of the Japanese version. Psychiatry Clin Neurosci. 2007;61:602-609. (Pubitemid 350233482)
14. Sumiyoshi T, Higuchi Y, Kawasaki Yet al. Electrical brain activity and response to olanzapine in schizophrenia: a study with LORETA images of P300. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:1299-1303. (Pubitemid 44216070)
15. Araki T, Kasai K, Rogers MA, et al. The effect of perospirone on auditory P300 in schizophrenia: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:1083-1090. (Pubitemid 43928224)
16. Kato T, Hirose A, Ohno Y, et al. Binding profile of SM-9018, a novel antipsychotic candidate. Jpn J Pharmacol. 1990;54: 478-481.
17. Sumiyoshi T, Stockmeier CA, Overholser JC, et al. Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia. Brain Res. 1996;708:209-214.
18. Sumiyoshi T, Meltzer HY. Serotonin 1A receptors in memory function. Am J Psychiatry. 2004;161:1505.
19. Umbricht D, Javitt D, Novak G, et al. Effects of clozapine on auditory event-related potentials in schizophrenia. Biol Psychiatry. 1998;44:716-725. (Pubitemid 28496787)
20. Higuchi Y, Sumiyoshi T, Kawasaki Y, et al. Effect of tandospirone on mismatch negativity and cognitive performance in schizophrenia: a case report. J Clin Psychopharmacol. 2010;30:732-734.